Table 4 Adverse events by treatment groups
Type of adverse event | Lumentin 44 (n = 18) | Omnipaque (n = 12) | MoviPrep (n = 14) | |||
|---|---|---|---|---|---|---|
Adverse events (n) | Patients, n (%) | Adverse events (n) | Patients, n (%) | Adverse events (n) | Patients, n (%) | |
Gastrointestinal disorders | 10 | 7 (38.9) | 13 | 7 (58.3) | 14 | 8 (57.1) |
Abdominal distension | 1 | 1 (5.6) | 1 | 1 (8.3) | 1 | 1 (7.1) |
Epigastralgia | 1 | 1 (5.6) | 3 | 3 (25.0) | 3 | 3 (21.4) |
Diarrhoea | 0 | 0 (0.0) | 3 | 3 (25.0) | 6 | 6 (42.9) |
Eructation | 1 | 1 (5.6) | 0 | 0 (0.0) | 0 | |
Flatulence | 4 | 4 (22.2) | 4 | 4 (33.3) | 3 | 3 (21.4) |
Nausea | 2 | 2 (11.1) | 2 | 2 (16.7) | 1 | 1 (7.1) |
Rectal haemorrhage | 1 | 1 (5.6) | 0 | 0 (0.0) | 0 | 0 (0.0) |
General disorder, chills | 0 | 0 (0.0) | 1 | 1 (8.3) | 0 | 0 (0.0) |